Category

Description

Company Summary

VL58, Inc. is a privately held, early-stage biotechnology company developing a novel approach to gene editing and gene therapy that can address diseases that are untreatable with current approaches like CRISPR or AAVs.

VL58 was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 40 groundbreaking companies over the past fifteen years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Seres Therapeutics (NASDAQ:MCRB), Moderna, Syros Pharmaceuticals (SYRS), Rubius Therapeutics (RUBY), Axcella Health, Evelo Biosciences (EVLO), and Indigo Agriculture.

Position Summary

The Biochemistry and Molecular Biology Senior/Principal Scientist will lead a growing team responsible for the advancement of VL58

Get In Touch